Go Pro

Heartflow (NASDAQ:HTFL) Trading 6.5% Higher - Time to Buy?

Heartflow logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Heartflow shares rose 6.5% to about $44.66, with trading volume below the average daily level. The stock’s market capitalization is approximately $3.85 billion, while its negative P/E ratio reflects ongoing losses.
  • Analysts remain broadly positive, with a “Moderate Buy” consensus, including one Strong Buy and eight Buy ratings. Piper Sandler raised its price target to $45, while the average target stands at $43.43.
  • Heartflow exceeded quarterly loss expectations, reporting an adjusted loss of $0.07 per share versus the anticipated $0.22 loss, while revenue grew 47.7% year over year to $64.08 million. However, the company continues to post negative margins, and insiders have sold more than 106,000 shares over the past 90 days.
  • MarketBeat previews the top five stocks to own by September 1st.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report)'s share price rose 6.5% during trading on Tuesday . The company traded as high as $44.32 and last traded at $44.6610. Approximately 1,241,238 shares traded hands during mid-day trading, a decline of 17% from the average session volume of 1,490,980 shares. The stock had previously closed at $41.94.

Analyst Ratings Changes

Several research analysts have commented on the company. Piper Sandler reaffirmed an "overweight" rating and issued a $45.00 price target (up from $38.00) on shares of Heartflow in a research report on Friday. Wells Fargo & Company increased their price objective on Heartflow from $37.00 to $39.00 and gave the company an "overweight" rating in a research report on Friday. Robert W. Baird set a $45.00 target price on shares of Heartflow in a research report on Friday. Benchmark reiterated a "buy" rating on shares of Heartflow in a research note on Friday. Finally, Weiss Ratings upgraded shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $43.43.

Get Our Latest Research Report on Heartflow

Heartflow Stock Up 6.4%

The firm has a 50-day moving average of $29.35 and a 200 day moving average of $27.85. The stock has a market capitalization of $3.85 billion and a P/E ratio of -24.39.

Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.50%. The company had revenue of $64.08 million during the quarter. The firm's revenue for the quarter was up 47.7% on a year-over-year basis. Analysts predict that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO John C.M. Farquhar sold 22,562 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $28.31, for a total value of $638,730.22. Following the completion of the transaction, the chief executive officer directly owned 436,280 shares of the company's stock, valued at approximately $12,351,086.80. This represents a 4.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 106,586 shares of company stock worth $3,269,343 over the last 90 days. 7.70% of the stock is currently owned by insiders.

Institutional Trading of Heartflow

A number of large investors have recently bought and sold shares of the stock. XXEC Inc. bought a new position in shares of Heartflow during the second quarter valued at $2,524,764,000. Wellington Management Group LLP increased its position in shares of Heartflow by 20.8% during the 4th quarter. Wellington Management Group LLP now owns 5,894,070 shares of the company's stock worth $171,812,000 after purchasing an additional 1,014,006 shares in the last quarter. BlackRock Inc. bought a new position in Heartflow during the 2nd quarter valued at about $152,502,000. Bamco Inc. NY acquired a new position in Heartflow in the second quarter valued at about $94,625,000. Finally, Jupiter Topco LLC bought a new stake in Heartflow during the second quarter worth about $70,983,000.

About Heartflow

(Get Free Report)

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Heartflow Right Now?

Before you consider Heartflow, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.

While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines